Business Segments Changchun High-Tech Industry (Group) Co., Ltd.
Stocks
000661
CNE0000007J8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.48 CNY | -4.56% |
|
+10.00% | -21.69% |
| 06-23 | China Approves Changchun High-Tech Industry Arm's Early Puberty Injection | MT |
| 06-11 | Changchun High-Tech Industry Gets China Approval for Eyelid Movement Treatment | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Industry | 10.05B | 11.95B | 13.61B | 12.67B | 11.17B | |||||
Total Assets | 13.66B | 17.69B | 22.28B | 21.6B | 20.66B | |||||
Income Tax Expense | 707M | 712M | 716M | 426M | 4.33M | |||||
EBT | 4.6B | 5.03B | 5.63B | 3.24B | 88.25M | |||||
D&A | 95.73M | 423M | 549M | 620M | 804M | |||||
Net Income | 3.89B | 4.32B | 4.91B | 2.82B | 83.93M | |||||
Real Estate | 663M | 804M | 915M | 756M | 859M | |||||
Total Assets | 6.28B | 6.28B | 6.23B | 6.54B | 7.23B | |||||
Income Tax Expense | 26.01M | 18.97M | 22.68M | 6.15M | 19.39M | |||||
EBT | 111M | 86.52M | 96.55M | 20.86M | 21.5M | |||||
D&A | 693K | 6.63M | 5.91M | 5.8M | 18.9M | |||||
Net Income | 84.59M | 67.56M | 73.87M | 14.71M | 2.1M | |||||
Service Industry | 36.97M | 36.44M | 44.11M | 46.24M | 86.19M | |||||
Total Assets | 13.41B | 14.57B | 15.89B | 15.77B | 16.42B | |||||
Income Tax Expense | 915K | 48.11K | - | - | -136K | |||||
EBT | 1.4B | 2.22B | 1.84B | 2.15B | 1.62B | |||||
D&A | 3.82M | 6.94M | 8.33M | 8.57M | 9.54M | |||||
Net Income | 1.4B | 2.22B | 1.84B | 2.15B | 1.62B | |||||
Offset of Business Segment | - | -162M | -5.92M | -3.18M | -33.62M | |||||
Total Assets | -10.83B | -12.52B | -13.66B | -12.86B | -14.23B | |||||
Income Tax Expense | -14.39M | -21.92M | -4.21M | -144K | 415K | |||||
EBT | -1.49B | -2.41B | -2.05B | -2.27B | -1.73B | |||||
D&A | -191K | -895K | 14.05M | 31.69M | -4.98M | |||||
Net Income | -1.48B | -2.39B | -2.05B | -2.27B | -1.73B | |||||
Total Assets | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
China | - | - | - | 13.34B | 11.94B | |||||
Foreign | 32.74M | 36.07M | 54.9M | 130M | 144M | |||||
Hong Kong | 5M | - | - | - | - | |||||
Southwest Region | 1.33B | 1.55B | 1.82B | - | - | |||||
Central China | 1.27B | 1.47B | 1.73B | - | - | |||||
Northwestern Region | 477M | 493M | 618M | - | - | |||||
Southern China | 1.23B | 1.6B | 1.85B | - | - | |||||
East China | 4.14B | 5.03B | 5.37B | - | - | |||||
Northeast China Region | 1.2B | 1.22B | 1.6B | - | - | |||||
Northern China | 1.07B | 1.24B | 1.52B | - | - |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition